All Stories

  1. Pilot study for the evaluation and adaptation of a Four Item-Acne-Scar Risk Assessment Tool (4-ASRAT): a resource to estimate the risk of acne-induced scars
  2. Identifying the Impacts of Acne: A Delphi Survey of Patients and Clinicians
  3. Characterizing high-burden rosacea subjects: a multivariate risk factor analysis from a global survey
  4. Facilitating Informed Treatment Decisions in Acne: A Pilot Study of a Patient Decision Aid
  5. Putting the Patient in Patient-Centred Care: Pilot Testing an Updated Patient Decision Aid for Plaque Psoriasis
  6. Development of a Comprehensive Quality-of-Life Measure for Facial and Torso Acne
  7. Assessing the Need for a Comprehensive Acne Quality-of-Life Scale for Face and Torso Acne
  8. Preliminary Validation of the HS-QoL: A Quality-of-Life Measure for Hidradenitis Suppurativa
  9. Defining treatment success in rosacea as ‘clear’ may provide multiple patient benefits: results of a pooled analysis
  10. Reconsidering Accuracy of Acne Self-Reports
  11. The Utility of Assessing Neck Acne
  12. Development of a Quality-of-Life Measure for Hidradenitis Suppurativa
  13. Canadian Clinical Practice Guidelines for Rosacea
  14. Development and Evaluation of a Rosacea Screening Instrument (Rosascreen)
  15. Evaluation of Evidence for Acne Remission With Oral Isotretinoin Cumulative Dosing of 120-150 mg/kg
  16. Perceptions on the Psychological Impact of Facial Erythema Associated with Rosacea: Results of International Survey
  17. Reliability of Clinician Erythema Assessment grading scale
  18. Open-label exploratory study of acitretin for the treatment of severe chronic hand dermatitis
  19. Treatment of facial erythema in patients with rosacea with topical brimonidine tartrate: correlation of patient satisfaction with standard clinical endpoints of improvement of facial erythema
  20. Evaluation of Clinical Severity by Acne Grading and Lesion Counting
  21. Rosacea: Current state of epidemiology
  22. Evaluation of essential clinical components and features of current acne global grading scales
  23. Acne severity grading: Determining essential clinical components and features using a Delphi consensus
  24. A Patient Decision Aid for Psoriasis Based on Current Clinical Practice Guidelines
  25. Evaluation of the French version of the 4-item index of the Acne-QoL (AcneQ4fr)
  26. Commentary on ‘Combined oral contraceptive pills for treatment of acne’
  27. The efficacy of adapalene-benzoyl peroxide combination increases with number of acne lesions
  28. Clinically relevant advances in acne management with adapalene 0.1%/benzoyl peroxide 2.5% gel
  29. Critical Appraisal of Quality of Clinical Practice Guidelines for Treatment of Psoriasis Vulgaris, 2006–2009
  30. Synergistic efficacy of adapalene 0.1%-benzoyl peroxide 2.5% in the treatment of 3855 acne vulgaris patients
  31. The safety profile and sustained remission associated with response to multiple courses of intramuscular alefacept for treatment of chronic plaque psoriasis
  32. Efficacy and safety of combined ethinyl estradiol/drospirenone oral contraceptives in the treatment of acne
  33. Current measures for the evaluation of acne severity
  34. Condensation and validation of a 4-item index of the Acne-QoL
  35. Randomized controlled trial of pimecrolimus 1% cream for treatment of facial acne vulgaris
  36. Hormonal Treatment of Acne: Review of Current Best Evidence
  37. Safety and Efficacy of Tacrolimus Ointment 0.1% (Protopic™) in Atopic Dermatitis: A Canadian Open-Label Multicenter Study
  38. Oral retinoids in the treatment of psoriasis
  39. The canadian acne epidemiological survey: baseline demographics and interim analysis
  40. Oral tazarotene reduces comedones
  41. Effects of oral tazarotene on health-related quality of life in patients with severe nodulocystic acne: results from a phase ii dose-ranging study
  42. Attitudes of Female Patients Regarding Oral Contraceptives for Treatment of Acne
  43. Beliefs and perceptions of patients with acne
  44. Treatment of Severe Alopecia Areata with Topical Diphenylcyclopropenone and 5% Minoxidil: A Clinical and Immunopathologic Evaluation
  45. Pooled Analysis of the Efficacy of Bacille Calmette-Guerin (BCG) Immunotherapy in Malignant Melanoma
  46. Treatment of chronic severe alopecia areata with topical diphenylcyclopropenone and 5% minoxidil: A clinical and immunopathologic evaluation
  47. Identifying effective treatments for uremic pruritus